Vitamin D levels in Coronavirus-infected Individuals and its Correlation with Certain Hematological Markers
Abstract
The world and nearly all our health care system were confronted by a significant threat which was declared by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Determining the SARS-CoV-2 or COVID-19’s prognostic and modifiable measures surely would largely contribute to outcome improving despite the deficiency of causative therapy that affected nearly 200 million people, 3.5 million fatal incidences, and it is still airborne. The research in hand examined probable relations between the levels of vitamin D (VitD) and immunological markers. Hence, a sample of 200 lecturers and students from Cihan University-Erbil were assigned, (150 males, 50 females) whom ages were between 22 to 25, with some respondents were treated from a previous COVID-19 infection. The results showed that 98 (or 49%) of the 200 samples had Covid-19 infection. Males 60/98 had a greater prevalence rate (61%), whilst females 38/98 had a lower rate (39%). According to immunological ELISA results, every patient had positive IgG antibodies and negative IgM antibodies. Compared to the healthy group, the serum levels of IgE rose considerably in Covid-19 patients. However, when compared to the healthy group, the serum level of vitamin D3 in the Covid-19 recovered patients showed a considerable reduction. The mean results for hematological parameters indicated a non-significant increase in the number of red blood cells relative to the healthy group, but a significant increase in the WBC count, Hb concentration, and platelets. Thus, the result indicates the necessity for interventional studies on vitamin D supplementation in SARS-CoV-2 infected persons by showing a correlation between vitamin D deficit and WBC count during COVID-19 recovery.
Downloads
References
Z. Song, Y. Xu, L. Bao, L. Zhang, P. Yu, Y. Qu, H. Zhu, W. Zhao, Y. Han and C. Qin. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, vol. 11, no. 1, p. 59, 2019.
C. Drosten, S. Günther, W. Preiser, S. Van der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier, A. Berger, A. M. Burguière, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J. C. Manuguerra, S. Müller and V. Rickerts. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine, vol. 348, no. 20, pp. 1967-1976, 2003.
S. Felsenstein, J. A. Herbert, P. S. McNamara and C. M. Hedrich. COVID-19: Immunology and treatment options. Clinical Immunology, vol. 215, p. 108448, 2020.
A. M. Rasheed, D. F. Fatak, H. A. Hashim, M. F. Maulood, K. K. Kabah, Y. A. Almusawi and A. S. Abdulamir. The therapeutic effectiveness of convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in Baghdad, Iraq. Le Infezioni in Medicina, vol. 28, pp. 357-366, 2020.
O. S. Habib, A. K. AlKanan and N. Q. Mohammed. Epidemiological features of COVID-19 epidemic in Basrah-Southern Iraq-first report. The Medical Journal of Basrah University, vol. 38, no. 1, pp. 7-18, 2020.
M. A. Ibrahim and A. Al-Najafi. Modeling, control, and prediction of the spread of COVID-19 using compartmental, logistic, and gauss models: A case study in Iraq and Egypt. Processes, vol. 8, no. 11, p. 1400, 2020.
N. Ali. Role of vitamin D in preventing of COVID-19 infection, progression and severity. Journal of Infection and Public Health, vol. 13, no. 10, pp. 1373-1380, 2020.
Z. Maghbooli, M. A. Sahraian, M. Ebrahimi, M. Pazoki, S. Kafan, H. M. Tabriz, A. Hadadi, M. Montazeri, M. Nasiri, A. Shirvani and M. F. Holick. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PloS One, vol. 15, no. 9, p.e0239799, 2020.
A. Mittal, K. Manjunath, R. K. Ranjan, S. Kaushik, S. Kumar and V. Verma. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2. PLoS Pathogens, vol. 16, no. 8, p. e1008762, 2020.
N. Vankadari and J. A. Wilce. Emerging COVID-19 coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerging Microbes and Infections, vol. 9, no. 1, pp. 601-604, 2020.
G. Feketea, V. Vlacha, I. C. Bocsan, E. Vassilopoulou, L. A. Stanciu and M. Zdrenghea. Vitamin D in corona virus disease 2019 (COVID-19) related multisystem inflammatory syndrome in children (MIS-C). Frontiers in Immunology, vol. 12, p. 648546, 2021.
W. B. Grant, H. Lahore, S. L. McDonnell, C. A. Baggerly, C. B. French, J. L. Aliano and H. P. Bhattoa. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, vol. 12, no. 4, p. 988, 2020.
T. S. Salih, A. S. M. Juma and M. H. Ubeid. Occupational exposures and associated health effects among dumpsite workers. Cihan University-Erbil Scientific Journal, vol. 5, no. 2, pp. 1-5, 2021.
J. Cannell, R. Vieth, J. C. Umhau, M. F. Holick, W. B. Grant, S. Madronich, C. F. Garland and E. Giovannucci. Epidemic influenza and vitamin D. Epidemiology and Infection, vol. 134, no. 6, pp. 1129-1140, 2006.
A. A. Ginde, J. M. Mansbach and C. A. Camargo Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National health and nutrition examination survey. Archives of Internal Medicine, vol. 169, no. 4, pp.384-390, 2009.
C. L. Greiller and A. R. Martineau. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, vol. 7, no. 6, pp. 4240-4270, 2015.
R. Bouillon, C. Marcocci, G. Carmeliet, D. Bikle, J. H. White, B. Dawson-Hughes, P. Lips, C. F. Munns, M. Lazaretti-Castro, A. Giustina and J. Bilezikian. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocrine Reviews, vol. 40, no. 4, pp. 1109-1151, 2019.
M. H. Ubeid. Interlukin-6 Levels in Relation to COVID-19 Vaccine. In: 4th International Conference on Biological and Health Sciences (CIC-BIOHS’2022). CIhan University-Erbil, Iraq, 2022.
M. H. Ubeid, T. S. Salih and A. S. M. Juma. HIV, HBS and HCV in dump site workers of Erbil governorate. Cihan University-Erbil Scientific Journal, vol. 5, no. 2, pp. 20-23, 2021.
T. Hai, F. A. Alenizi, M. H. Ubeid, V. Goyal, F. M. Alhomayani and A. S. M. Metwally. Using machine learning for comparative optimizing a novel integration of molten carbonate and solid oxide fuel cells with CO2 recovering and gasification. International Journal of Hydrogen Energy, vol. 48, no. 97, pp. 38454-3847, 2023.
Copyright (c) 2024 Muhsin H. Ubeid, Ameena S. M. Juma, Shakir M. Al-Awqati, Tanya S. Salih, Muhamed A. Abbas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
